Status:
UNKNOWN
Macular Pigment Optical Density in Primary Angle-closure Disease
Lead Sponsor:
Zhongshan Ophthalmic Center, Sun Yat-sen University
Conditions:
Glaucoma
Glaucoma, Angle-Closure
Eligibility:
All Genders
40-90 years
Brief Summary
Glaucoma is the leading cause of irreversible blindness in the world, and primary angle-closure glaucoma (PACG) is the most important type of glaucoma in Asia. Primary angle closure disease (PACD) is ...
Detailed Description
Observation index： Visual acuity，Intraocular pressure，Ophthalmoscope，MPOD，Visual field and OCT. Inspection parameters of OCT： 1. Retinal nerve fiber layer thickness 2. Ganglion cell complex thicknes...
Eligibility Criteria
Inclusion
- Experimental group：
- (1) According to the diagnostic criteria of PACD
- (2)History of peripheral iridectomy or trabeculectomy
- (3)Over 40
- (4)Phakic eyes
- (5)Intraocular pressure is less than 21mmhg, more than one week
- (6)Eyes with clear optical media.
- Control group：
- (1)No history of glaucoma and other eye diseases
- (2)Phakic eyes
- (3)Over 40
- (4)Intraocular pressure10\~21mmHg
Exclusion
- (1)History of corneal diseases
- (2)History of eye tumor or other ophthalmic surgery
- (3)Cataract
- (4)Taking supplements containing lutein within 6 months
- (5)Snellen's visual acuity was less than 6 / 20，the diopter is beyond ± 6 degrees
Key Trial Info
Start Date :
November 11 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05251792
Start Date
November 11 2021
End Date
December 30 2024
Last Update
February 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhognshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, Guangdong, China, 510060